Tokyo Tape
Sign in
← Cytori Cell Research Institute

Quarterly report · Q2

3750.TEDINET S100S7YU
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥863m2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥2.1bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥1.2bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income−¥354m2023-04-01 → 2023-09-30Cons.Operating income
Operating income−¥381m2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income−¥424m2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income−¥862m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥437m2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax−¥419m2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax−¥539m2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)−¥443m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥1.1bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥561m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income−¥443m2023-04-01 → 2023-09-30Cons.Profit loss
Net income−¥561m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥13.6bnat 2023-09-30Cons.Assets
Total assets¥14.1bnat 2023-03-31Cons.Assets
Total assets¥14.2bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥11.4bnat 2023-09-30Cons.Liabilities
Total liabilities¥11.4bnat 2023-03-31Cons.Liabilities
Net assets / equity¥2.2bnat 2023-09-30Cons.Net assets
Net assets / equity¥2.7bnat 2023-03-31Cons.Net assets
Net assets / equity¥3.2bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥658mat 2023-09-30Cons.Cash and deposits
Cash and deposits¥1.1bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥208mat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥673mat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥561mat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥702mat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow−¥367m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥40m2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥20m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥3m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥283m2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥94m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥94m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥294m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥67m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-49.652023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-31.592023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-118.712022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-62.862022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-30.662022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio14.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio17.3%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio20.6%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30−¥87m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentrevenue2023-04-01 → 2023-09-30¥45m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentrevenue external2023-04-01 → 2023-09-30¥45m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentsegment profit2023-04-01 → 2023-09-30−¥285m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentrevenue2023-04-01 → 2023-09-30¥818m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentrevenue external2023-04-01 → 2023-09-30¥818m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentsegment profit2023-04-01 → 2023-09-30¥17m
—segment totalrevenue2023-04-01 → 2023-09-30¥863m
—segment totalrevenue external2023-04-01 → 2023-09-30¥863m
—segment totalsegment profit2023-04-01 → 2023-09-30−¥267m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30−¥74m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentrevenue2022-04-01 → 2022-09-30¥84m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentrevenue external2022-04-01 → 2022-09-30¥84m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentsegment profit2022-04-01 → 2022-09-30−¥119m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentrevenue2022-04-01 → 2022-09-30¥1.1bn
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.1bn
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentsegment profit2022-04-01 → 2022-09-30−¥188m
—segment totalrevenue2022-04-01 → 2022-09-30¥1.2bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥1.2bn
—segment totalsegment profit2022-04-01 → 2022-09-30−¥307m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 442
ItemContextValueUnit
Valuation difference on available for sale securitiesPrior1YearInstant66000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant143000JPY
Valuation and translation adjustmentsPrior1YearInstant66000JPY
Valuation and translation adjustmentsCurrentQuarterInstant143000JPY
Subscription rights to sharesPrior1YearInstant211501000JPY
Subscription rights to sharesCurrentQuarterInstant211501000JPY
Non controlling interestsPrior1YearInstant4007000JPY
Non controlling interestsCurrentQuarterInstant4409000JPY
Net assetsPrior1YearInstant2656682000JPY
Net assetsCurrentQuarterInstant2213719000JPY
Liabilities and net assetsPrior1YearInstant14091635000JPY
Liabilities and net assetsCurrentQuarterInstant13598409000JPY
Net salesPrior1YTDDuration1172744000JPY
Net salesCurrentYTDDuration862531000JPY
Cost of salesPrior1YTDDuration634678000JPY
Cost of salesCurrentYTDDuration134423000JPY
Gross profitPrior1YTDDuration538065000JPY
Gross profitCurrentYTDDuration728108000JPY
Salaries and allowances sgaPrior1YTDDuration202797000JPY
Salaries and allowances sgaCurrentYTDDuration214725000JPY
Depreciation sgaPrior1YTDDuration140627000JPY
Depreciation sgaCurrentYTDDuration104837000JPY
Other sgaPrior1YTDDuration575626000JPY
Other sgaCurrentYTDDuration762617000JPY
Selling general and administrative expensesPrior1YTDDuration919050000JPY
Selling general and administrative expensesCurrentYTDDuration1082180000JPY
Operating incomePrior1YTDDuration-380985000JPY
Operating incomeCurrentYTDDuration-354071000JPY
Insurance income noiPrior1YTDDuration－JPY
Insurance income noiCurrentYTDDuration3085000JPY
Subsidy income noi bountyPrior1YTDDuration22758000JPY
Subsidy income noi bountyCurrentYTDDuration－JPY
Interest subsidy noiPrior1YTDDuration2365000JPY
Interest subsidy noiCurrentYTDDuration2167000JPY
Other noiPrior1YTDDuration3423000JPY
Other noiCurrentYTDDuration4713000JPY
Non operating incomePrior1YTDDuration28548000JPY
Non operating incomeCurrentYTDDuration9966000JPY
Interest expenses noePrior1YTDDuration59664000JPY
Interest expenses noeCurrentYTDDuration79310000JPY
Arrangement fee noePrior1YTDDuration25000000JPY
Arrangement fee noeCurrentYTDDuration－JPY
Other noePrior1YTDDuration269000JPY
Other noeCurrentYTDDuration112000JPY
Non operating expensesPrior1YTDDuration84934000JPY
Non operating expensesCurrentYTDDuration79422000JPY
Ordinary incomePrior1YTDDuration-437370000JPY
Ordinary incomeCurrentYTDDuration-423528000JPY
Other eiPrior1YTDDuration0JPY
Other eiCurrentYTDDuration－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass